Read More

Diffusion Pharmaceuticals Announced Issuance of U.S. Patent 11,185,523 ‘Use of Bipolar Trans Carotenoids With Chemotherapy and Radiotherapy for Treatment of Cancer’

Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) ("Diffusion" or the "Company"), a biopharmaceutical company developing novel therapies that enhance the body's ability to deliver oxygen to areas where it is needed most, today announced that it has been granted United States Patent No.

DFFN